MAZE
NASDAQ · Pharmaceuticals
Maze Therapeutics Inc
$22.52
-0.92 (-3.92%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
-9.49%
YTD
-43.37%
Open$23.27
Previous Close$23.44
Day High$23.57
Day Low$22.01
52W High$53.65
52W Low$22.45
Volume—
Avg Volume552.7K
Market Cap1.31B
P/E Ratio—
EPS$-2.51
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$42.71
Below
SMA 200
$25.83
Below
RSI (14)
50.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
18 analysts
Price Target
+317.0% upside
Current
$22.52
$22.52
Target
$93.90
$93.90
$74.59
$93.90 avg
$145.81
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 190.13M | 546.10M | 525.77M |
| Net Income | 20.86M | 109.70M | 88.79M |
| Profit Margin | 11.0% | 20.1% | 16.9% |
| EBITDA | 69.11M | 173.82M | 160.69M |
| Free Cash Flow | — | 65.89M | 67.30M |
| Rev Growth | — | +21.9% | +7.3% |
| Debt/Equity | — | 0.74 | 0.66 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |